the landscape of oral serds and their potential in er breast cancer
Published 6 months ago • 151 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
2:35
what does the future hold for serds in er breast cancer?
-
0:50
serds for patients with er /her2- breast cancer
-
18:40
overview of clinical data of serds & their place in treatment landscape
-
1:27
emerald: elacestrant vs physicians choice in er /her2- breast cancer
-
1:51
ameera-3: serd for er her2- breast cancer
-
0:55
cambria-1: camizestrant vs standard endocrine therapy in breast cancer
-
2:52
future research directions for breast cancer
-
2:35
ameera-6: amcenestrant, a novel serd, in hr breast cancer
-
37:38
understanding the current and future role of oral serds (selective estrogen receptor degraders) i...
-
1:15:47
evolving landscape of hr-positive metastatic breast cancer: a year in review
-
1:05
cambria 1: camizestrant er /her2- early breast cancer
-
20:37
gs2-02: "elacestrant, an oral selective estrogen receptor degrader (serd), vs investigator’s..."
-
1:16:18
serds at the inflection point in pretreated er /her2- breast cancer: novel er-targeting therapies
-
34:06
the emerging role of serd's in hr breast cancer
-
37:53
addressing the challenge of endocrine-resistant breast cancer
-
37:38
understanding the current and future role of oral serds (selective estrogen receptor degraders) i...
-
2:06
elaine 1: esr1 mutations in ctdna from er /her2- mbc treated with lasofoxifene or fulvestrant